GlaxoSmithKline
GSK
#208
Rank
โ‚ฌ84.11 B
Marketcap
41,67ย โ‚ฌ
Share price
-0.82%
Change (1 day)
31.70%
Change (1 year)

GlaxoSmithKline (GSK) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ20.47 Billion

According to GlaxoSmithKline's latest financial reports the company's total debt is โ‚ฌ20.47 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

GlaxoSmithKline - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ20.48 B-1.35%
2023-12-31โ‚ฌ20.76 B-12.27%
2022-12-31โ‚ฌ23.66 B-17.85%
2021-12-31โ‚ฌ28.81 B-4.24%
2020-12-31โ‚ฌ30.08 B-15.75%
2019-12-31โ‚ฌ35.71 B23.48%
2018-12-31โ‚ฌ28.92 B50.24%
2017-12-31โ‚ฌ19.24 B-12.67%
2016-12-31โ‚ฌ22.04 B-2.22%
2015-12-31โ‚ฌ22.54 B-6.26%
2014-12-31โ‚ฌ24.04 B10.34%
2013-12-31โ‚ฌ21.79 B-2.55%
2012-12-31โ‚ฌ22.36 B25.39%
2011-12-31โ‚ฌ17.83 B1.77%
2010-12-31โ‚ฌ17.52 B-4.56%
2009-12-31โ‚ฌ18.36 B8.2%
2008-12-31โ‚ฌ16.96 B17.87%
2007-12-31โ‚ฌ14.39 B76.73%
2006-12-31โ‚ฌ8.14 B-24.01%
2005-12-31โ‚ฌ10.72 B27.09%
2004-12-31โ‚ฌ8.43 B16.5%
2003-12-31โ‚ฌ7.24 B1.67%
2002-12-31โ‚ฌ7.12 B2.27%
2001-12-31โ‚ฌ6.96 B9.01%
2000-12-31โ‚ฌ6.38 B13.34%
1999-12-31โ‚ฌ5.63 B28.88%
1998-12-31โ‚ฌ4.37 B4.54%
1997-12-31โ‚ฌ4.18 B-10.66%
1996-12-31โ‚ฌ4.68 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
โ‚ฌ27.99 B 36.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ52.20 B 155.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ35.49 B 73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ27.47 B 34.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ21.90 B 7.00%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.64 B-28.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.24 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA